Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Subscribe To Our Newsletter & Stay Updated
